Tax withheld4

Astrana Health, Inc.

Total Value

$3.7K

Filing Date

Sep 17, 2026

1 transactions

Trade Summary

On Sep 15, 2026, Vong John, SVP - Accounting (PAO), reported $3.7K of Astrana Health, Inc. (ASTH) across 1 transactions. The filing covers Common Stock and reflects balanced net activity of $0. Reported prices ranged from $38.35. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Vong John
Role: SVP - Accounting (PAO)
Location: ALHAMBRA, CA

Filing Details

Filing Date: Sep 17, 2026
Transaction Date: Sep 15, 2026
Accession Number: 0001104659-26-108627
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Sep 15, 2026	Common Stock	96	$38.35	Tax Withholding	$3.7K

Want live alerts when Vong John trades again?

Download Insider Trades to track ASTH, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 15, 2026.
(F2)Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 3,104 restricted stock units, which will vest in two equal semi-annual installments beginning on October 10, 2026; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.
(F3)Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vong John

(Last)

(First)

(Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA

91801

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP - Accounting (PAO)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/15/2026		F		96⁽¹⁾	D	$38.35	22,330⁽²⁾⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 15, 2026.

2. Includes 3,972 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 380 shares which will vest on November 30, 2026; and (ii) tranches of 454 shares, 454 shares, 454 shares, 454 shares, and 1,776 shares, each of which will vest in two equal semi-annual installments beginning on November 12, 2026. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 3,104 restricted stock units, which will vest in two equal semi-annual installments beginning on October 10, 2026; and (ii) 1,887 restricted stock units, which will vest in seven equal semi-annual installments beginning March 15, 2027.

3. Includes 584 shares acquired under the Issuer's Employee Stock Purchase Plan.

	/s/ Kimberly Pham, as Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001104659-26-108627.

Astrana Health, Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when Vong John trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4